by Brad N. Taylor, Ph.D. | Apr 6, 2022
Scaling up cell culture media for your cellular therapy doesn’t have to be grueling; Nucleus Biologics simplifies formulation testing, scale-up, and re-ordering to make your life easier. Last week, we discussed media potency and how changing even one cell culture...
by Brad N. Taylor, Ph.D. | Mar 23, 2022
Nucleus Biologics to distribute a groundbreaking cell culture media system, Krakatoa™, which is designed to deliver high-quality, custom-made cell culture media at its maximum potency. Last week, we introduced the 4 pillars that form the foundation of Krakatoa™, a...
by Brad N. Taylor, Ph.D. | Mar 8, 2022
Nucleus Biologics recently announced the distribution of Krakatoa™, a point-of-use media manufacturing system aimed at improving the industry’s environmental impact. Nucleus Biologics plans to cure people + planet. Not many biologics companies have such bold goals,...
by Brad N. Taylor, Ph.D. | Feb 28, 2022
Krakatoa’s point of use media manufacturing reduces greenhouse gas emissions by 65% per unit of media produced. (San Diego, CA – February 28, 2022) Nucleus Biologics, The Cell Performance Company™, is proud to announce the launch of Krakatoa™, an innovative,...